Legal & General Group’s ASP Isotopes ASPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$245K Sell
55,426
-21,085
-28% -$125K ﹤0.01% 2505
2025
Q4
$409K Buy
76,511
+68,134
+813% +$542K ﹤0.01% 2470
2025
Q3
$80.6K Buy
8,377
+1,953
+30% +$18K ﹤0.01% 2655
2025
Q2
$47.3K Sell
6,424
-60
-0.9% -$402 ﹤0.01% 2719
2025
Q1
$30.4K Buy
6,484
+945
+17% +$4.71K ﹤0.01% 2811
2024
Q4
$25.1K Sell
5,539
-541
-9% -$2.88K ﹤0.01% 2945
2024
Q3
$16.9K Buy
6,080
+1,692
+39% +$4.5K ﹤0.01% 3115
2024
Q2
$13.4K Buy
+4,388
New +$16.9K ﹤0.01% 3198

Other funds holding ASPI

Legal & General Group's ASPI Position: Q1 2026 in Review

Legal & General Group reduced its ASP Isotopes (ASPI) stake by 28% in Q1 2026, selling an estimated $125K and leaving 55,426 shares worth $245K. The position accounts for ﹤0.01% of the portfolio, ranked #2505.

Legal & General Group first reported a position in ASPI in Q2 2024 and has held it in 8 quarters since. The position peaked at $409K in Q4 2025. 177 funds tracked by Wall St. Rank hold ASPI as of Q1 2026.

  • Legal & General Group held 55,426 shares of ASP Isotopes worth $245K as of Q1 2026.
  • Legal & General Group sold 21,085 ASP Isotopes shares in Q1 2026, an estimated $125K.
  • ASP Isotopes made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2505 holding.
  • Legal & General Group first reported a position in ASP Isotopes in Q2 2024 and has held it in 8 quarters since.
  • Legal & General Group's ASP Isotopes position peaked at $409K in Q4 2025.
  • 177 funds tracked by Wall St. Rank held ASP Isotopes as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.